Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis

Published:2017 Issue:35 Volume:5 Page:7216-7237
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Azria David¹²³⁴⁵^ORCID,Blanquer Sébastien¹²³⁴⁵,Verdier Jean-Michel⁶⁷⁸⁵⁹,Belamie Emmanuel¹²³⁴⁵^ORCID

Affiliation:

1. Institut Charles Gerhardt Montpellier

2. UMR 5253 CNRS-UM-ENSCM

3. Equipe Matériaux Avancés pour la Catalyse et la Santé

4. 34296 Montpellier Cedex 5

5. France

6. Ecole Pratique des Hautes Etudes

7. PSL Research University

8. 75014 Paris

9. INSERM 1198 – Unité mixte UM – EPHE

Abstract

A comprehensive review of recent advances in the development of nanoparticle-based contrast agents for the diagnosis of AD by MRI.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2017/TB/C7TB01599B

Reference305 articles.

1. The projected effect of risk factor reduction on Alzheimer's disease prevalence

2. Forecasting the global burden of Alzheimer's disease

3. Is the risk of Alzheimer’s disease and dementia declining?

4. Defeating Alzheimer's disease and other dementias: a priority for European science and society

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanobiosensing disease diagnostics for in vivo applications;Handbook of Nanomaterials, Volume 2;2024

2. A review on nanotechnological perspective of “the amyloid cascade hypothesis” for neurodegenerative diseases;International Journal of Biological Macromolecules;2023-12

3. The recent progress of ion exchange for the separation of rare earths from secondary resources – A review;Hydrometallurgy;2023-04

4. Conclusions and Perspectives;Nanomedicine;2023

5. In vivo targeting and multimodal imaging of cerebral amyloid-β aggregates using hybrid GdF₃ nanoparticles;Nanomedicine;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3